Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
899.50
11.5 (1.3%)
BSENSE

Dec 05

BSE+NSE Vol: 701

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
111.05
111.48
115.68
84.41
90.03
80.08
91.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
111.05
111.48
115.68
84.41
90.03
80.08
91.98
Raw Material Cost
54.05
49.98
52.29
36.79
38.91
37.43
47.73
Purchase of Finished goods
1.02
7.98
6.50
1.93
4.71
2.77
0.00
(Increase) / Decrease In Stocks
-0.44
0.07
2.01
0.02
0.33
-1.18
-1.70
Employee Cost
13.31
12.15
12.68
11.07
10.31
9.73
9.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
17.77
17.13
16.31
17.11
16.12
13.98
16.32
Total Expenditure (Excl Depreciation)
85.70
87.31
89.78
66.91
70.38
62.73
71.35
Operating Profit (PBDIT) excl Other Income
25.35
24.17
25.90
17.50
19.65
17.35
20.63
Other Income
0.90
0.38
0.77
0.65
0.22
0.28
0.58
Operating Profit (PBDIT)
26.25
24.55
26.67
18.15
19.87
17.63
21.21
Interest
2.84
2.76
2.49
2.20
2.71
2.48
3.06
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-7.10
Gross Profit (PBDT)
23.41
21.79
24.18
15.95
17.16
15.15
11.05
Depreciation
4.96
4.76
5.09
4.56
4.62
4.03
5.07
Profit Before Tax
18.45
17.03
19.07
11.39
12.55
11.12
5.98
Tax
4.33
5.11
4.59
2.87
4.10
2.77
1.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
14.12
11.92
14.48
8.52
8.46
8.35
4.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
14.12
11.92
14.48
8.52
8.46
8.35
4.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.01
-0.01
-0.01
-0.01
-0.01
-0.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.12
11.93
14.49
8.53
8.47
8.36
4.36
Equity Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
13.6
11.49
13.96
8.22
8.16
8.05
4.2
Diluted Earnings per share
13.6
11.49
13.95
8.21
8.15
8.04
4.08
Operating Profit Margin (Excl OI)
22.83%
21.68%
22.39%
20.73%
21.83%
21.67%
22.43%
Gross Profit Margin
21.08%
19.55%
20.9%
18.9%
19.06%
18.92%
12.01%
PAT Margin
12.71%
10.69%
12.52%
10.09%
9.4%
10.43%
4.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 23.35% vs 29.26% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 66.71% vs 35.74% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 29.01% vs 29.02% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 4.80% vs 12.45% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Kwality Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
111.05
77.99
33.06
42.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
111.05
77.99
33.06
42.39%
Raw Material Cost
54.05
16.11
37.94
235.51%
Purchase of Finished goods
1.02
18.23
-17.21
-94.40%
(Increase) / Decrease In Stocks
-0.44
-10.19
9.75
95.68%
Employee Cost
13.31
24.93
-11.62
-46.61%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17.77
32.01
-14.24
-44.49%
Total Expenditure (Excl Depreciation)
85.70
81.09
4.61
5.69%
Operating Profit (PBDIT) excl Other Income
25.35
-3.10
28.45
917.74%
Other Income
0.90
3.24
-2.34
-72.22%
Operating Profit (PBDIT)
26.25
0.14
26.11
18,650.00%
Interest
2.84
2.76
0.08
2.90%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
23.41
-2.62
26.03
993.51%
Depreciation
4.96
2.57
2.39
93.00%
Profit Before Tax
18.45
-3.45
21.90
634.78%
Tax
4.33
0.16
4.17
2,606.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.12
-5.36
19.48
363.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.12
-5.36
19.48
363.43%
Share in Profit of Associates
0.00
1.74
-1.74
-100.00%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.12
-3.62
17.74
490.06%
Equity Capital
10.38
9.20
1.18
12.83%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.60
-0.39
13.99
3,587.18%
Diluted Earnings per share
13.60
-0.39
13.99
3,587.18%
Operating Profit Margin (Excl OI)
22.83%
-3.97%
0.00
26.80%
Gross Profit Margin
21.08%
-3.36%
0.00
24.44%
PAT Margin
12.71%
-4.64%
0.00
17.35%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 111.05 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -0.39% vs -3.63% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 23.35% vs 29.26% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.12 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 18.36% vs -17.67% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 66.71% vs 35.74% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.35 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.88% vs -6.68% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 29.01% vs 29.02% in Sep 2024

Quarterly - Interest
Interest 2.84 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 2.90% vs 10.84% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 4.80% vs 12.45% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.83%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024